Literature DB >> 19321697

Identification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis.

Eric R LaFontaine1, Lauren E Snipes, Brian Bullard, Aimee L Brauer, Sanjay Sethi, Timothy F Murphy.   

Abstract

Moraxella catarrhalis is a common cause of respiratory tract infection in the setting of chronic obstructive pulmonary disease (COPD). Adults with COPD acquire and clear strains of M. catarrhalis from the respiratory tract continuously and develop strain-specific protection following clearance of a strain. In previous work, we identified Hag/MID (Moraxella immunoglobulin D-binding protein), a large multifunctional surface protein that acts as an adhesin and hemagglutinin, as a target of antibody responses in adults with COPD after clearance of M. catarrhalis. The goal of the present study was to characterize the domains of Hag/MID to which humans make antibodies, including both systemic and mucosal antibody responses. Analysis of recombinant peptide constructs, which spanned the M. catarrhalis strain O35E Hag/MID protein, with well-characterized serum and sputum samples revealed that most adults with COPD made antibodies directed toward a region of the molecule bounded by amino acids 706 to 863. Serum immunoglobulin G (IgG) and IgA purified from sputum both recognized the same domain. Some flanking sequence of this fragment was necessary for the epitope(s) in this region to maintain its conformation to bind human antibodies. These results reveal that humans consistently generate both systemic and mucosal antibody responses to an immunodominant region of the Hag/MID molecule, which was previously shown to overlap with several biologically relevant domains, including epithelial cell adherence, IgD binding, collagen binding, and hemagglutination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321697      PMCID: PMC2681595          DOI: 10.1128/CVI.00460-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  35 in total

Review 1.  Type V protein secretion pathway: the autotransporter story.

Authors:  Ian R Henderson; Fernando Navarro-Garcia; Mickaël Desvaux; Rachel C Fernandez; Dlawer Ala'Aldeen
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

Review 2.  Trimeric autotransporters: a distinct subfamily of autotransporter proteins.

Authors:  Shane E Cotter; Neeraj K Surana; Joseph W St Geme
Journal:  Trends Microbiol       Date:  2005-05       Impact factor: 17.079

3.  The IgD-binding domain of the Moraxella IgD-binding protein MID (MID962-1200) activates human B cells in the presence of T cell cytokines.

Authors:  Therése Nordström; Johan Jendholm; Martin Samuelsson; Arne Forsgren; Kristian Riesbeck
Journal:  J Leukoc Biol       Date:  2005-11-21       Impact factor: 4.962

4.  Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Christoph Aebi; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Hag directly mediates the adherence of Moraxella catarrhalis to human middle ear cells.

Authors:  Brian Bullard; Serena L Lipski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

6.  Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response.

Authors:  Timothy F Murphy; Aimee L Brauer; Brydon J B Grant; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2005-04-01       Impact factor: 21.405

7.  Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Christoph Aebi; Sanjay Sethi
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

8.  The CD19 molecule is crucial for MID-dependent activation of tonsillar B cells from children.

Authors:  R Hadzic; A Forsgren; L-O Cardell; K Riesbeck; A G Wingren
Journal:  Scand J Immunol       Date:  2005-02       Impact factor: 3.487

9.  The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro.

Authors:  E R Lafontaine; L D Cope; C Aebi; J L Latimer; G H McCracken; E J Hansen
Journal:  J Bacteriol       Date:  2000-03       Impact factor: 3.490

10.  Biofilm formation by Moraxella catarrhalis in vitro: roles of the UspA1 adhesin and the Hag hemagglutinin.

Authors:  Melanie M Pearson; Cassie A Laurence; Sarah E Guinn; Eric J Hansen
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more
  13 in total

1.  Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion.

Authors:  Suzanne J C Verhaegh; Kim Stol; Corné P de Vogel; Kristian Riesbeck; Eric R Lafontaine; Timothy F Murphy; Alex van Belkum; Peter W M Hermans; John P Hays
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

Review 2.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

3.  Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children.

Authors:  Dabin Ren; Anthony L Almudevar; Timothy F Murphy; Eric R Lafontaine; Anthony A Campagnari; Nicole Luke-Marshall; Michael E Pichichero
Journal:  Vaccine       Date:  2017-07-26       Impact factor: 3.641

4.  Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children.

Authors:  Dabin Ren; Anthony L Almudevar; Timothy F Murphy; Eric R Lafontaine; Anthony A Campagnari; Nicole Luke-Marshall; Janet R Casey; Michael E Pichichero
Journal:  Vaccine       Date:  2015-09-21       Impact factor: 3.641

5.  Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin.

Authors:  Timothy F Murphy; Aimee L Brauer; Melinda M Pettigrew; Eric R LaFontaine; Hervé Tettelin
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

6.  Bacterium-generated nitric oxide hijacks host tumor necrosis factor alpha signaling and modulates the host cell cycle in vitro.

Authors:  Brian Mocca; Wei Wang
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

Review 7.  Panel 6: Vaccines.

Authors:  Stephen I Pelton; Melinda M Pettigrew; Stephen J Barenkamp; Fabrice Godfroid; Carlos G Grijalva; Amanda Leach; Janak Patel; Timothy F Murphy; Sanja Selak; Lauren O Bakaletz
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

Review 8.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 9.  Vaccine targets against Moraxella catarrhalis.

Authors:  Dabin Ren; Michael E Pichichero
Journal:  Expert Opin Ther Targets       Date:  2015-08-26       Impact factor: 6.902

Review 10.  Molecular aspects of Moraxella catarrhalis pathogenesis.

Authors:  Stefan P W de Vries; Hester J Bootsma; John P Hays; Peter W M Hermans
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.